News

Bronner Gonçalves, Epidemiologist, London School of Hygiene and Tropical Medicine, has released a new article on the ‘Group B streptococcus infection during pregnancy and infancy: estimates of regional and global burden’, in Lancet Global Health April 2022. “Better ways to prevent Group B Streptococcus infection are urgently needed to save babies on all continents and avoid the long-term consequences to their lives and their families.” Bronner Gonçalves, Epidemiologist, LSHTM Group B streptococcus (GBS) colonisation during Read more…

Proma Paul, Research Fellow, London School of Hygiene and Tropical Medicine, has released a new manuscript on the ‘Neurodevelopmental and growth outcomes after invasive Group B Streptococcus in early infancy: A multi-country matched cohort study in South Africa, Mozambique, India, Kenya, and Argentina’, in Lancet eClinical Medicine 2022. Data are limited regarding long-term consequences of invasive GBS (iGBS) disease in early infancy, especially from low- and middle-income countries (LMIC), where most cases occur. We aimed Read more…

“Every Country, Every Family: Group B Streptococcal Disease Worldwide” is a series of nine papers coordinated by LSHTM, funded by the Bill & Melinda Gates Foundation and involving 61 authors from 6 continents. Please find access to the supplement here: https://academic.oup.com/cid/issue/74/Supplement_1?login=false The supplement in Clinical Infectious Diseases presents long term outcomes including detailed neurodevelopment from South Africa, Mozambique, India and novel epidemiological big data analyses from Denmark and the Netherlands, as well as economic outcomes Read more…

Congratulations to Abeba Mengist, Assistant Professor of Medical Microbiology in Debre Markos University, Ethiopia. Abeba’s poster submission ‘Vaginal Group B Streptococcus Colonization: Prevalence, Associated Factors and Antimicrobial Susceptibility pattern among Pregnant Women in Jimma, Ethiopia’, was awarded best poster prize by the attendees of the 2nd International Symposium on ‘Streptococcus agalactiae’ Disease that took place online 3rd – 5th November 2021. The poster prize includes flights, visas and a contributions towards accommodation for Abeba to attend the Read more…

ISSAD is excited to announce that Dr Carol J. Baker will be taking part in moderating Track 1 at the ISSAD Conference in November. Formerly a professor of paediatrics, molecular virology and microbiology at Baylor College of Medicine (BCM) from 1975-2018. Dr Baker made groundbreaking recognition of neonatal and young infant group B streptococcal disease and its correlation of lack of maternal antibodies to the GBS capsular polysaccharide during her infectious diseases fellowship training at Read more…

ISSAD are excited to announce that the below speakers will be taking part in the keynote sessions at the ISSAD Conference in November. Dr Kate O’Brien will be taking part as a keynote speaker on the first day of the conference. In her role, she is responsible for leading WHO’s strategy and implementation to advance the vision of a world where everyone, everywhere, at every age, fully benefits from vaccines for good health and wellbeing. Read more…

Thank you for viewing our new ISSAD.org website, to optimise your experience to attend the ISSAD virtual conference on identifying and preventing morbidity and mortality caused by Streptococcus agalactiae. The hybrid conference takes place 3 – 5 November 2021. The conference will be fully virtual but with some in-person attendance at BMA House (depending on Covid-19 restrictions). Abstract submissions open on Monday 17th May 2021 and close on Monday 12th July 2021 midnight BST. Please Read more…